Every other month, researchers find new uses for GLP-1 agonist drugs, like Mounjaro and Ozempic — now even as a treatment for substance abuse. It's classic drug repurposing, a technique that saved lives during COVID.
The list of uses for GLP-1 agonist drugs keeps growing: It started as a treatment for type 2 diabetes, then got hyped as a weight-loss jab.
There's also evidence that GLP-1 agonists, like semaglutide and tirzepatide — sold as Mounjaro, Ozempic, Wegovy and Zepound —
lower the risk of cardiovascular diseases
protect the kidney and the liver,
reduce inflammation and pain,
Is the growing use of GLP-1s reshaping ideas of Black beauty?
Here’s how GLP-1 drugs could save your life, as well as make you slim
New Study Suggests GLP-1 Use Might Lower Your Chances Of Developing This Common Cancer
AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying
Why drugs like Ozempic might reduce cancer risk
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than…
Research suggests GLP-1s like Ozempic may help with more than just weight loss and type 2 diabetes, but experts warn of risks…
A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.
As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for both…
According to a new study, GLP-1s may be potentially effective in reducing chronic inflammation.
People across the Black diaspora are increasingly turning to weight-loss drugs. How might this reshape our health, wellbeing and…
